Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125294314 | 12529431 | 4 | F | 2016 | 20160825 | 20160706 | 20160829 | EXP | SE-ROCHE-1789238 | ROCHE | 75.00 | YR | F | Y | 0.00000 | 20160829 | MD | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125294314 | 12529431 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | ||||||||
| 125294314 | 12529431 | 2 | SS | BENDAMUSTINE | BENDAMUSTINE | 1 | Intravenous (not otherwise specified) | 0 | 90 | MG/M**2 | |||||||||
| 125294314 | 12529431 | 3 | SS | TROMBYL | ASPIRIN | 1 | Unknown | 0 | 75 | MG | QD | ||||||||
| 125294314 | 12529431 | 4 | C | RADIATION TREATMENT | RADIATION THERAPY | 1 | Unknown | 0 | |||||||||||
| 125294314 | 12529431 | 5 | C | DELTISON | PREDNISONE | 1 | Unknown | 0 | 50 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125294314 | 12529431 | 1 | B-cell lymphoma |
| 125294314 | 12529431 | 2 | B-cell lymphoma |
| 125294314 | 12529431 | 3 | Product used for unknown indication |
| 125294314 | 12529431 | 4 | B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125294314 | 12529431 | DE |
| 125294314 | 12529431 | DS |
| 125294314 | 12529431 | HO |
| 125294314 | 12529431 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125294314 | 12529431 | Aphasia | |
| 125294314 | 12529431 | Blood albumin decreased | |
| 125294314 | 12529431 | Blood potassium decreased | |
| 125294314 | 12529431 | Confusional state | |
| 125294314 | 12529431 | Hemiparesis | |
| 125294314 | 12529431 | Ileus | |
| 125294314 | 12529431 | Leukocytosis | |
| 125294314 | 12529431 | Memory impairment | |
| 125294314 | 12529431 | Progressive multifocal leukoencephalopathy | |
| 125294314 | 12529431 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125294314 | 12529431 | 1 | 201505 | 201510 | 0 | |
| 125294314 | 12529431 | 2 | 201505 | 201510 | 0 | |
| 125294314 | 12529431 | 3 | 2016 | 0 | ||
| 125294314 | 12529431 | 4 | 2015 | 201602 | 0 | |
| 125294314 | 12529431 | 5 | 2016 | 0 |